Theranos Investor Conference Presentation Deck

T Cell, B Cell, NK Cells (TBNK, Lymphocyte Subset): Precision Study Overview Sample type and matrix Control levels Study Design Analysis Quality control material (R&D Systems Status Flow) CD4 Low (all other analytes normal) CD4 Normal (all other analytes normal) 3 miniLabs x 5 Days x 5 Tests per day (CLSI EP05-A3) Analysis of variance to determine repeatability, within-lab variability, and reproducibility This technology has not been cleared or approved by the FDA and is not for sale in the United States. theranos 41

View entire presentation